IMA
ImageneBio Inc
NASDAQ · USHealthcareBiotechnology
$5.73+6.51%
Price as of Jul 20, 2026
IMA capital
ImageneBio Inc capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- 0.07x
- Net debt / equity
- -0.55x
- Debt / assets
- 0.06x
- Debt / EBITDA
- -0.16x
- Net debt / EBITDA
- 1.31x
Liquidity & coverage
- Current ratio
- 18.39x
- Quick ratio
- 18.39x
- Cash ratio
- 17.67x
- Interest coverage
- -582.57x
- EBITDA / interest
- -537.91x
- Working capital
- $115.4M
Cash & dividend
- FCF / debt
- -6.39x
- Cash flow / debt
- -6.39x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.